0.938
0.94 (0%)
As of Dec 24, 2024
Spero Therapeutics, Inc. [SPRO]
Source:
Company Overview
Spero Therapeutics, Inc is a multi-asset, clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (“MDR”) bacterial infections with high unmet need.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | (857) 242-1600 |
Industry | manufacturing |
CEO | Satyavrat Shukla |
Website | www.sperotherapeutics.com |